Answers are grounded in this paper and cite their sources.
Staphylococcus aureus infection impairs bone repair, but how bacterial proteins disrupt osteogenic progenitors remains unclear. The bacterial chaperone DnaK promotes glutathione peroxidase 4 (GPX4) degradation in bone marrow mesenchymal stem cells (BMSCs), accompanied by lipid peroxidation, ferroptotic injury, and impaired osteogenic differentiation. GPX4 protein turnover increases without a change in Gpx4 mRNA abundance. A candidate E3-ligase screen identifies the C terminus of Hsc70-interacting protein (CHIP) as a mediator of this response. Catalytically inactive CHIP attenuates DnaK-associated K48-linked GPX4 ubiquitination, while CHIP knockdown preserves GPX4 and osteogenic proteins in primary BMSCs. To target bacterial DnaK and host oxidative injury, a bone-targeted deoxyribozyme (DNAzyme)-nanozyme platform (DMPA) combines a dnaK-targeting DNAzyme with manganese hexacyanoferrate, polydopamine, and alendronate. In infected cultures, DMPA reduces bacterial dnaK transcript and DnaK protein abundance and improves BMSC redox balance and matrix mineralization. In a mouse model of infected tibial defects, DMPA promotes bone regeneration. These findings link bacterial DnaK to host GPX4 degradation through CHIP and establish a bone-targeted DNAzyme-nanozyme strategy that combines bacterial DnaK suppression with redox regulation to promote repair of infected bone defects.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: